Related Experiment Video
Updated: Jul 19, 2026

Visualization of Cell Cycle Variations and Determination of Nucleation in Postnatal Cardiomyocytes
Published on: February 24, 2017
The cardiomyocyte cell cycle
Pascal J E Lafontant1, Loren J Field
1Wells Center for Pediatric Research and Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN 46202-5225, USA.
Abstract:
Many forms of cardiac disease are characterized by cardiomyocyte death due to necrosis, apoptosis and/or oncosis. Recently, the notion of promoting cardiac regeneration as a means to replace damaged heart tissue has engendered considerable interest. One approach to accomplish heart muscle regeneration entails promoting cardiomyocyte cell cycle activity in the surviving myocardium. Genetically modified mice have provided useful model systems to test the efficacy of specific pathways to promote cardiomyocyte proliferation in normal and diseased hearts. For example, expression of a heart-restricted dominant interfering version of p193 (an E3 ubiquitin ligase also known as Cul7) resulted in an induction of cardiomyocyte cell cycle activity at the infarct border zone and ventricular septum 4 weeks after permanent coronary artery occlusion. A concomitant reduction in hypertrophic cardiomyocyte growth was also observed in this model, suggesting that cell cycle activation partially counteracted the adverse ventricular remodelling that occurs post-infarction. In other studies, targeted expression of cyclin D2 promoted cardiomyocyte cell cycle activity in adult hearts. The level of cardiomyocyte cell cycle activity increased after myocardial infarction, ultimately resulting in a marked increase in cardiomyocyte number and a concomitant regression of infarct size. Collectively, these data suggest that modulation of cardiomyocyte cell cycle activity can be exploited to promote regenerative growth in injured hearts.
Insights
Promoting cardiomyocyte cell cycle activity aids heart regeneration after injury. Strategies like manipulating p193 or cyclin D2 can increase cardiomyocyte numbers and reduce infarct size, offering a regenerative approach for cardiac repair.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Molecular Cardiology
Background:
- Cardiac diseases often lead to cardiomyocyte death via necrosis, apoptosis, or oncosis.
- Cardiac regeneration is a promising strategy to replace damaged heart tissue.
- Stimulating cardiomyocyte cell cycle activity in surviving heart muscle is a key approach for regeneration.
Purpose of the Study:
- To investigate methods for promoting cardiomyocyte cell cycle activity for cardiac regeneration.
- To evaluate the efficacy of genetic modifications in stimulating cardiomyocyte proliferation in damaged hearts.
Main Methods:
- Utilized genetically modified mouse models to study cardiomyocyte proliferation.
- Investigated the effects of expressing a dominant-interfering version of p193 (Cul7) in a heart-restricted manner.
- Examined the impact of targeted cyclin D2 expression in adult mouse hearts post-myocardial infarction.
Main Results:
- Expression of p193 induced cardiomyocyte cell cycle activity at the infarct border zone and septum, reducing hypertrophic growth.
- Targeted cyclin D2 expression increased cardiomyocyte cell cycle activity post-myocardial infarction.
- Both interventions led to increased cardiomyocyte numbers and reduced infarct size, suggesting regenerative potential.
Conclusions:
- Modulating cardiomyocyte cell cycle activity is a viable strategy for promoting regenerative growth in injured hearts.
- Genetic manipulation of specific pathways (e.g., p193, cyclin D2) can enhance cardiac repair post-infarction.
- Activating cardiomyocyte proliferation offers a potential therapeutic avenue to counteract adverse ventricular remodeling.
More Related Videos
Related Concept Videos
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System
The Cell Cycle Control System
Specialized Characteristics of Cardiac Muscles
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Positive Regulator Molecules
Positive Regulator Molecules

